莱美药业：AglaeaPharma项目平台已搭建多个技术平台、产品管线和系列产品

Core Viewpoint - Laimei Pharmaceutical has established a joint investment with AglaeaPharma to create a multi-target small molecule drug screening platform and an early disease detection and diagnostic technology development platform [1] Group 1 - The company has set up a new entity called Guangxi Aglaea, in collaboration with AglaeaPharma [1] - AglaeaPharma's project platform has developed multiple technical platforms, product pipelines, and a series of products [1] - The initiative aims to form a globally integrated innovative research and development system [1] Group 2 - The company will continue to monitor the project's progress and fulfill its information disclosure obligations in a timely manner [1]